INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy
January 25, 2023 07:45 ET
|
INmune Bio, Inc.
Boca Raton, Florida, Jan. 25, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...
Muscular Dystrophy Association Announces 2023 National Ambassador Leah Zelaya from New York
January 23, 2023 10:00 ET
|
Muscular Dystrophy Association
New York, NY, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) has selected 15-year-old Leah Zelaya from Brooklyn, New York, as its 2023 MDA National Ambassador. ...